A 52-year-old man with a history of malignant lymphoma of the cecum presented with lancinating facial pain in the left. Magnetic resonance imaging (MRI) revealed a tumor in the Meckel's cave extending along the trigeminal nerve. The tumor was partially removed via left retrosigmoid lateral suboccipital craniotomy. Histological examination showed fi ndings consistent with diffuse large B cell lymphoma, which was later confi rmed to be metastatic lesion from the cecal lesion. Postoperative chemotherapy with cyclophosphamide, high dose, cytarabine, steroid (dexamethasone), etoposide, and rituximab (CHASER) followed by whole brain irradiation (30 Gy) resulted in complete remission. Although facial pain persisted, the patient's general condition remained favorable and he did not experience recurrence over the 51 month follow-up period. Histological confi rmation and awareness of malignant lymphoma are very important to determine the therapeutic strategy and to avoid misdiagnosis or delayed diagnosis. Long-term survival of patients with metastatic malignant lymphoma in the Meckel's cave extending along the trigeminal nerve was very rare. In addition, metastatic malignant lymphoma in the extra-axial and peripheral nervous tissue might be different from primary central nervous system lymphoma in the white matter, since the effi cacy of chemotherapeutic agents against malignant lymphomas in the extra-axial regions is not attenuated by the blood brain barrier.
Introduction
Primary central nervous system lymphoma (PCNSL) usually arises in the white matter of the brain. Most of the lesions are supratentorial in a central location near an ependymal surface, but cases can sometimes occur in extra-axial regions. [1] [2] [3] [4] [5] [6] Despite the use of high-dose methotrexiate and radiation therapy over the past decade, the prognosis for patients with PCNSL remains dismal with a mean overall survival of 15 to 45 months, even after extensive chemotherapy and radiation. 7) Long-term survival is extremely rare in such patients. 2, 4) The present report describes a rare case of metastatic lymphoma in the Meckel's cave with perineural extension along the trigeminal nerve. Cyclophosphamide, high dose cytarabine, steroid (dexamethasone), etoposide, and rituximab (CHASER) therapy followed by whole brain irradiation resulted in long-term survival without adverse effect.
Case Report
A 52-year-old man presented with a left facial pain in May 2009. His medical history was notable for malignant lymphoma of the cecum that was treated by rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone (R-CHOP) therapy for eight cycles resulting in complete remission 1 year prior to his current presentation. Magnetic resonance imaging (MRI) showed a tumor in the left Meckel's cave with extension along the trigeminal nerve. The tumor was isointense on T 1 -and T 2 -weighted imaging with homogenous enhancement with gadolinium ( Fig. 1A-D) . To confi rm the diagnosis, retrosigmoid lateral
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Neurol Med Chir (Tokyo) 54, [677] [678] [679] [680] 2014 Neurol Med Chir (Tokyo) 54, August, 2014 suboccipital craniotomy was performed. The tumor was pinkish and encased the trigeminal nerve, and extended into the Meckel's cave. The tumor was easily detached from the trigeminal nerve fi ber and was partially removed ( Fig. 2A,B) . Histological fi ndings revealed the bizarre and large tumor cells were arranged in solid areas and predominant of nuclei with atypia and mitoses (Fig. 3A) . Many of tumor cells were positive for CD79α (Fig. 3B) , which was compatible with a diagnosis of diffuse large B cell lymphoma (DLBCL) that had metastasized to the Meckel's cave and the trigeminal nerve. Postoperatively, the patient's facial pain persisted but his postoperative course was uneventful. The patient received further CHASER therapy for three additional cycles resulting in complete remission. Since the regrowth of the tumor in the Meckel's cave was detected by MRI, whole brain irradiation (30 Gy) was administered, and the patient obtained complete remission again. Four years after biopsy, he remains alive with persistent left facial numbness. No recurrent tumor was found on MRI ( Fig. 4A-D) .
Discussion
The present report describes a case of metastatic malignant lymphoma along the peripheral nerve and in the extraaxial skull base. Many kinds of tumors can occur in the cerebellopontine angle in Meckel's cave including meningioma, trigeminal neurinoma, and epidermoid and metastatic carcinoma. These tumors are very diffi cult to obtain early diagnosis based only on preoperative neuroimaging. The clinical symptom and MR (magnetic resonance) images associated with the present tumor were similar to those of a trigeminal neurinoma. Previous reports have described misdiagnosis of malignant lymphoma as schwannoma or skull base meningioma. 4, 5) Therefore, histological confi rmation of tumors in this region is required to determine the appropriate treatment strategy, which might include any combination of surgery, radiosurgery, conventional radiation, or chemotherapy. Several reports have described primary and metastatic lymphomas at the skull base. [8] [9] [10] [11] Occasionally, malignant lymphoma can produce perineural infi ltration from the trigeminal nerve via the foramen ovale or transorbitally via the superior and inferior orbital. Malignant lymphoma in the trigeminal region or cerebellopontine angle can present in three patterns: (1) an extra-axial tumor, (2) an intra-axial tumor extending into the cerebellopontine angle, or (3) as leptomeningeal dissemination. 12) In the present case based on operative finding, the tumor was an extra-axial mass, and no tumor cells were detected in cerebrospinal fluid (CSF) cytology.
In the present case, primary malignant lymphoma was originated in the cecum and was completely cured in response to R-CHOP therapy. Since metastatic intracranial lymphoma is rare, we selected direct surgery to obtain defi nitive histological diagnosis. The present tumor was confi rmed to be recurrent metastatic malignant lymphoma invading the middle cranial fossa via the trigeminal nerve. Based on histological diagnosis and clinical course of the present case, we selected CHASER therapy along with whole brain irradiation, as the tumor recurred following R-CHOP therapy. The patient experienced remission in response to treatment, but recurrence of the tumor in the Meckel's cave was subsequently detected by MRI, and whole brain irradiation was administered, resulting in complete remission. As shown in Table 1 , additional whole brain irradiation obtained long-term survival of patients with intracranial malignant lymphoma.
According to the standard treatment guidelines, 13) PCNSL should be treated with high dose methotrexate combined with radiation therapy. Kinoshita et al. described a similar case of primary lymphoma located in the trigeminal region that experienced complete remission in response to high-dose methotrexate therapy and radiation, 5) but the patient died 14 months after treatment probably due to multiple organ failure. Quality of life for patients who survive PCNSL is not always good, because treatments can have adverse effects on the white matter, and thereby cause neurological defi cits and mental disorders.
Fortunately, the lymphoma in the present case was very sensitive to treatment with CHASER therapy followed by whole brain irradiation. The adverse effects of this regimen were mild and included nausea and grade 4 of thrombocytopenia and leukocytopenia, which was not lethal. In addition, the tumor was located in the extraaxial skull base along the peripheral nerve. Since the tumor was located outside the central nervous system, the blood brain barrier did not interfere with the effi cacy of chemotherapy regimen. Therapeutic agents are more effective when the metastatic intracranial lymphoma is located in the peripheral nervous tissue rather than in the white matter of the brain. In addition, metastases to other organs were not detected. These factors might have contributed to the favorable survival seen in the present case. However, the fact that there was a tumor in the Meckel's cave and cerebellopontine cistern should be carefully monitored to detect CSF dissemination is important. Patients with disease within the CSF should receive intrathecal chemotherapy.
In conclusion, malignant lymphoma in the trigeminal region is very rare, but it should be included with the differential diagnosis of tumors in the Meckel's cave. Histological examination of a needle biopsy or surgical specimen should be obtained in patients with new lesions and a past history of systemic lymphoma in order to avoid misdiagnosis or delayed diagnosis.
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